Mid-Atlantic Microbial Pathogenesis Meeting 2022
Mid-Atlantic Microbial Pathogenesis Meeting 2022
批准号:
10504721
负责人:
Robert K Ernst
金额:
$1.34万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-02-01 至 2023-01-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
The 11th Mid-Atlantic Microbial Pathogenesis Meeting (MAMPM) will be held February 13-15, 2022 at
Wintergreen Resort and Conference Center near Charlottesville, Virginia. The purpose of the MAMPM is to
foster communication and collaboration among microbial pathogenesis researchers in the Mid-Atlantic (NC,
VA, MD, DC, WV, and DE, though researchers from 12 states are now attending). Numerous FDA-funded
investigators studying the virulence mechanisms of pathogens of importance to human health are in this
geographic region and have participated in multiple MAMPMs. One of MAMPM’s key goals is to provide
students, postdoctoral fellows, and junior faculty with the opportunity to present their work to a knowledgeable
audience, focused on this discipline, in a collegial yet scientifically rigorous environment. Conference
evaluations consistently MAMPM is a formative experience for young scientists’ professional development and
remains one of the most appealing, and positively evaluated, aspects of this conference. All ten previous
meetings have been held at Wintergreen Resort Conference Center, which features a central location,
excellent facilities, and a professional conference staff. At our last meeting (2019), we achieved maximum
registration (201 attendees) for the first time.
MAMPM 2022 is arranged by the Organizing Committee, comprised of the current, future, and past two
conference chairs. The vast majority of the presenters are graduate students, postdoctoral fellows, and junior
faculty with four internationally renowned keynote speakers introduce each session. Drs. Tod Merkel (FDA
staff scientist), Virginia Miller (UNC), Leigh Knodler (WSU), and Martin Wiedmann (Cornell) are the MAMPM
2022 keynote speakers. In addition, two highly attended and interactive poster sessions will be provided to
allow the opportunity for all participants to present and discuss their work face-to-face. MAMPM 2022 will be
publicized through advertisements in professional publications, social media posts, and direct mailings
(physical and email) to relevant departments at academic institutions, government and private laboratories
within the region and to members of the local American Society for Microbiology branches that serve this
region. A dedicated website (http://mampm.org/) publicizes the meeting and provides the necessary
information and forms required for registration. MAMPM also strongly supports diversity in sex/gender,
race/ethnicity, age, and disability status. Drs. Ashley Haines and Carleitta Paige-Anderson will serve as
Diversity Ambassadors to enhance participation from underrepresented groups. MAMPM 2022 will feature the
MAMPM Advancing Diversity Initiative, with panels of diverse composition to discuss career transitions.
Finally, research presented at MAMPM is highly relevant to FDA's mission, particularly in the development
of novel vaccines, diagnostic and treatment platforms for the human diseases, and protection the public
against the threats of emerging infectious diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Microbial adaptation of Pseudomonas lipid A structure in CF airway disease progress
-
批准号:10722599
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2023
-
负责人:Robert K Ernst
-
依托单位:
MS Diagnostic Bacterial Identification Library
-
批准号:10116273
-
项目类别:
-
资助金额:$46.35万
-
财政年份:2020
-
负责人:Robert K Ernst
-
依托单位:
MS Diagnostic Bacterial Identification Library
-
批准号:10356152
-
项目类别:
-
资助金额:$46.35万
-
财政年份:2020
-
负责人:Robert K Ernst
-
依托单位:
MS Diagnostic Bacterial Identification Library
-
批准号:10570981
-
项目类别:
-
资助金额:$46.35万
-
财政年份:2020
-
负责人:Robert K Ernst
-
依托单位:
Protection Against Gram-Negative Sepsis Conferred by Lipid A-Based Structural Variants
-
批准号:9753900
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2016
-
负责人:Robert K Ernst
-
依托单位:
MS diagnostic bacterial identification library
-
批准号:8722128
-
项目类别:
-
资助金额:$27.74万
-
财政年份:2014
-
负责人:Robert K Ernst
-
依托单位:
Development of a Rationally Attenuated Live Vaccine for Francisella tularensis
-
批准号:8650788
-
项目类别:
-
资助金额:$23.03万
-
财政年份:2013
-
负责人:Robert K Ernst
-
依托单位:
Development of a Rationally Attenuated Live Vaccine for Francisella tularensis
-
批准号:8511015
-
项目类别:
-
资助金额:$19.19万
-
财政年份:2013
-
负责人:Robert K Ernst
-
依托单位:
Immunotherapeutic Potential of Modified Lipooligosaccharides and Lipid A's
-
批准号:8675799
-
项目类别:
-
资助金额:$23.02万
-
财政年份:2013
-
负责人:Robert K Ernst
-
依托单位:
Immunotherapeutic Potential of Modified Lipooligosaccharides and Lipid A's
-
批准号:8584054
-
项目类别:
-
资助金额:$18.04万
-
财政年份:2013
-
负责人:Robert K Ernst
-
依托单位:
Bacterial Lipopolysaccharide Structure
-
批准号:7637607
-
项目类别:
-
资助金额:$36.56万
-
财政年份:2008
-
负责人:Robert K Ernst
-
依托单位:
Pseudomonas aeruginosa lipid A
-
批准号:7476478
-
项目类别:
-
资助金额:$32.15万
-
财政年份:2001
-
负责人:Robert K Ernst
-
依托单位:
Pseudomonas aeruginosa lipid A
-
批准号:7681139
-
项目类别:
-
资助金额:$32.15万
-
财政年份:2001
-
负责人:Robert K Ernst
-
依托单位:
Pseudomonas aeruginosa lipid A
-
批准号:7911766
-
项目类别:
-
资助金额:$31.83万
-
财政年份:2001
-
负责人:Robert K Ernst
-
依托单位:
Pseudomonas aeruginosa lipid A
-
批准号:7147812
-
项目类别:
-
资助金额:$35.0万
-
财政年份:2000
-
负责人:Robert K Ernst
-
依托单位:
Pseudomonas aeruginosa lipid A
-
批准号:7254098
-
项目类别:
-
资助金额:$34.08万
-
财政年份:2000
-
负责人:Robert K Ernst
-
依托单位:
海外基金